Company News
Director dealings: Canal+, Optima Health executives acquire shares
Among the director dealing disclosures reported to the London market on Friday were two detailing share acquisitions by senior executives at Canal+ and Optima Health.
Gelion confident after reporting narrower EBITDA loss
Energy storage technology company Gelion reported total income of £2m in its final results on Friday, primarily from research and development tax incentives and grant income, consistent with market expectations.
Genedrive upbeat on publication of clinical performance data
Point-of-care pharmacogenetic testing specialist Genedrive announced on Friday that clinical performance data for its Genedrive CYP2C19-ID Kit had been published in the Journal of Molecular Biology.
Rome Resources receives subscription funds from Stanvic
Democratic Republic of the Congo-focussed tin explorer Rome Resources announced the receipt of subscription funds from Stanvic on Friday, as part of its strategic investment initiative.
Delivery Hero slumps as sale of Taiwan subsidiary to Uber blocked
Delivery Hero tumbled on Friday after the sale of its Taiwan subsidiary to Uber Technologies was blocked.
Two killed in further unrest near Gemfields Mozambique venture
Gemfields updated the market on the unrest in Mozambique on Thursday, reporting two deaths as “illegal” ruby mining groups exploited ongoing political instability.
Operations continuing at Kenmare mine despite Mozambique unrest
Titanium minerals and zircon-focused miner Kenmare Resources has reassured investors that operations at its Moma project in Mozambique are continuing as normal despite civil unrest spreading across the country.
Syncona investment sells cancer study assets to AstraZeneca for $12m
Life science investor Syncona said its investment Achilles Therapeutics has sold cancer study assets to AstraZeneca for $12m (£9. 58m).
SRT Marine Systems commences new Middle East contract
Maritime tech group SRT Marine Systems has said it has kicked off a new maritime domain awareness contract worth $9m over a 10-year period.